March 29, 2019
Mayo Clinic in the News Weekly Highlights for March 29, 2019
By Emily Blahnik 
Reuters, Biogen scraps two Alzheimer drug trials, wipes $18 billion from market value by Julie Steenhuysen — Biogen Inc and partner Eisai Co Ltd are ending two late-stage trials of their experimental Alzheimer’s disease drug aducanumab, a major setback in the quest to find a treatment for the mind-wasting disease and a blow to Biogen, […]
View full entry
Tags: AliveCor, alzheimer's disease, anal cancer, artificial Intelligence, Biogen, blood donation, Blood Donor Program, caffeine, cognitive decline, dementia, depression, Derrick Rose
March 22, 2019
Mayo Clinic in the News Weekly Highlights for March 22, 2019
By Emily Blahnik 
New York Times, When Email Comes to the Doctor’s Office, Wait Times Decrease by Austin Frakt — Most studies report high satisfaction from specialists, but one found that a large minority (26 percent) of them were dissatisfied. The concerns expressed included unclear clinical questions and the possible liability associated with providing medical advice for patients […]
View full entry
Tags: allergy season, Alliance to HEAL, alzheimer's disease, arthritis, Aspirin, asthma, Bret Adler, burnout, C-SPAN, CABANA, Chad Corey, chicken pox
June 26, 2014
Mayo Clinic in the News Weekly Highlights
By Karl Oestreich 
Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations Wall Street Journal Obesity Is Undercounted in […]
View full entry
Tags: 3D mammograms, ABC News Australia, ABC30, aging, Agnes Rapacz, Allevant Solutions, alzheimer's disease, American News Report, angina, ANSA, anti-obesity devic, AP